![logo](/logos/ECOR.webp)
electroCore, Inc.
NASDAQ:ECOR
5.94 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | electroCore, Inc. |
Symbool | ECOR |
Munteenheid | USD |
Prijs | 5.94 |
Beurswaarde | 38,294,408 |
Dividendpercentage | 0% |
52-weken bereik | 4.9 - 8.08 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Daniel S. Goldberger |
Website | https://www.electrocore.com |
An error occurred while fetching data.
Over electroCore, Inc.
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)